Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/14 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 69
- 較 2023 年第 2 季 +7
- 總值
- $3.06 億
- 較 2023 年第 2 季 +$5,197 萬 (+20.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| APGEApogee Therapeutics, Inc. | COM | 1,045,110 | $2,226 萬 | 7.3% | +1,045,110 | 新進 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 2,000,000 | $2,040 萬 | 6.7% | +400,000+25.0% | 加碼 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,129,376 | $1,684 萬 | 5.5% | +79,258+7.5% | 加碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $1,641 萬 | 5.4% | – | – | – |
| CERECerevel Therapeutics Holdings, Inc. | COM | 685,061 | $1,495 萬 | 4.9% | +135,061+24.6% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 400,000 | $1,435 萬 | 4.7% | +173,725+76.8% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 450,000 | $1,338 萬 | 4.4% | +450,000 | 新進 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 85,000 | $1,241 萬 | 4.1% | −7,500−8.1% | 減碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 239,108 | $1,173 萬 | 3.8% | +27,500+13.0% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 300,000 | $1,152 萬 | 3.8% | +40,000+15.4% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 300,438 | $1,026 萬 | 3.4% | +240,062+397.6% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 856,535 | $781.2 萬 | 2.6% | −53,782−5.9% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 1,000,300 | $746.2 萬 | 2.4% | +349,425+53.7% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 230,366 | $678.7 萬 | 2.2% | +105,218+84.1% | 加碼 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 57,500 | $667.0 萬 | 2.2% | +57,500 | 新進 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,018,091 | $658.7 萬 | 2.2% | +117,368+13.0% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 270,000 | $618.6 萬 | 2.0% | +68,113+33.7% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 368,329 | $600.4 萬 | 2.0% | −79,338−17.7% | 減碼 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 1,379,852 | $579.5 萬 | 1.9% | +628,056+83.5% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 1,992,466 | $464.2 萬 | 1.5% | +403,449+25.4% | 加碼 | 歷史 |
| SVRASavara Inc | COM | 1,150,000 | $434.7 萬 | 1.4% | +1,150,000 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 46,400 | $434.5 萬 | 1.4% | −11,360−19.7% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 150,000 | $412.8 萬 | 1.3% | +62,969+72.4% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 60,000 | $406.3 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 350,000 | $394.1 萬 | 1.3% | +350,000 | 新進 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 79,214 | $382.2 萬 | 1.2% | −20,786−20.8% | 減碼 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 2,850,000 | $361.9 萬 | 1.2% | +2,850,000 | 新進 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 300,000 | $332.1 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 242,297 | $296.8 萬 | 1.0% | +46,297+23.6% | 加碼依 1 比 25 拆股換算 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 200,000 | $295.4 萬 | 1.0% | +200,000 | 新進 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 50,000 | $285.0 萬 | 0.9% | +50,000 | 新進 | 歷史 |
| ALKSAlkermes plc. | SHS | 100,000 | $280.1 萬 | 0.9% | +100,000 | 新進 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 278,292 | $268.0 萬 | 0.9% | +100,000+56.1% | 加碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 60,426 | $263.2 萬 | 0.9% | +60,426 | 新進 | 歷史 |
| IMTXImmatics N.V. | SHS | 200,000 | $231.6 萬 | 0.8% | −100,000−33.3% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 50,000 | $229.8 萬 | 0.8% | +50,000 | 新進 | 歷史 |
| SGENSeagen Inc. | COM | 10,000 | $212.2 萬 | 0.7% | +10,000 | 新進 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 30,000 | $208.4 萬 | 0.7% | +30,000 | 新進 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 250,000 | $196.5 萬 | 0.6% | +150,000+150.0% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 150,000 | $175.2 萬 | 0.6% | +150,000 | 新進 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 325,000 | $163.5 萬 | 0.5% | +325,000 | 新進 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 40,000 | $152.2 萬 | 0.5% | +30,000+300.0% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 25,000 | $127.5 萬 | 0.4% | +11,077+79.6% | 加碼 | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 6,293 | $124.9 萬 | 0.4% | +6,293 | 新進 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 125,000 | $115.6 萬 | 0.4% | +25,000+25.0% | 加碼 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 400,000 | $112.4 萬 | 0.4% | +200,000+100.0% | 加碼 | 歷史 |
| THRXTheseus Pharmaceuticals, Inc. | COM | 400,726 | $107.8 萬 | 0.4% | +160,482+66.8% | 加碼 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 335,068 | $103.9 萬 | 0.3% | +35,000+11.7% | 加碼 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 672,357 | $100.2 萬 | 0.3% | −128,319−16.0% | 減碼 | 歷史 |
| ADCTADC Therapeutics SA | SHS | 1,100,000 | $98.7 萬 | 0.3% | +500,000+83.3% | 加碼 | 歷史 |
| IFRXInflaRx N.V. | COM | 325,097 | $96.9 萬 | 0.3% | +84,897+35.3% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 41,581 | $96.1 萬 | 0.3% | −88,419−68.0% | 減碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 30,000 | $94.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 100,000 | $89.4 萬 | 0.3% | +100,000 | 新進 | 歷史 |
| PODDInsulet Corp | Stock | 5,000 | $79.7 萬 | 0.3% | +5,000 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 30,000 | $79.1 萬 | 0.3% | −5,133−14.6% | 減碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 30,156 | $78.4 萬 | 0.3% | +30,156 | 新進 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 500,000 | $77.0 萬 | 0.3% | +500,000 | 新進 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $66.3 萬 | 0.2% | 00.0% | 不變 | – |
| PBYIPuma Biotechnology, Inc. | COM | 202,349 | $53.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM | 265,958 | $52.7 萬 | 0.2% | +265,958 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 328,817 | $49.7 萬 | 0.2% | +61,243+22.9% | 加碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 250,000 | $33.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BCABBioAtla, Inc. | COM | 180,000 | $30.6 萬 | 0.1% | −145,000−44.6% | 減碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 44,348 | $29.6 萬 | 0.1% | −105,652−70.4% | 減碼 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 137,000 | $26.0 萬 | 0.1% | +100,000+270.3% | 加碼 | 歷史 |
| NLS Pharmaceutics LtdH57830103 | SHS | 200,455 | $14.0 萬 | <0.1% | −199,545−49.9% | 減碼 | – |
| ARAVAravive, Inc. | COM | 346,511 | $4.57 萬 | <0.1% | +346,511 | 新進 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $7,500 | <0.1% | 00.0% | 不變 | – |
選擇權（12 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $1,122 萬 |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | $696.5 萬 | – |
| ESTAEstablishment Labs Holdings Inc. | COM | – | $687.0 萬 |
| ALKSAlkermes plc. | SHS | – | $560.2 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | $494.5 萬 | – |
| IMVTImmunovant, Inc. | COM | $491.8 萬 | – |
| VKTXViking Therapeutics, Inc. | COM | $368.2 萬 | – |
| ACRSAclaris Therapeutics, Inc. | COM | $178.1 萬 | – |
| EYPTEyePoint, Inc. | COM NEW | $123.8 萬 | – |
| MORFMorphic Holding, Inc. | COM | $114.5 萬 | – |
| ETNB89bio, Inc. | COM | – | $57.6 萬 |
| MESOMesoblast Ltd | SPONS ADR | $49.2 萬 | – |
2023 年第 2 季之後清倉（15 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 2 季股數 | 2023 年第 2 季市值 | 2023 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| KDNYChinook Therapeutics, Inc. | COM | 321,017 | $1,233 萬 | 4.9% | 歷史 |
| BIIBBiogen Inc. | COM | 40,000 | $1,139 萬 | 4.5% | 歷史 |
| Esperion Therapeutics Inc Ne29664WAB1 | NOTE 4.000%11/1 | – | $344.1 萬 | 1.4% | – |
| VTYXVentyx Biosciences, Inc. | COM | 100,696 | $330.3 萬 | 1.3% | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 29,105 | $296.8 萬 | 1.2% | 歷史 |
| KYNBKyntra Bio, Inc. | COM | 983,300 | $265.5 萬 | 1.0% | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 1,492,771 | $194.1 萬 | 0.8% | 歷史 |
| CABACabaletta Bio, Inc. | COM | 125,000 | $161.4 萬 | 0.6% | 歷史 |
| Intrexon Corp46122TAA0 | NOTE 3.500% 7/0 | – | $150.7 萬 | 0.6% | – |
| WHWKWhitehawk Therapeutics, Inc. | COM | 187,675 | $128.4 萬 | 0.5% | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 118,891 | $122.2 萬 | 0.5% | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 62,500 | $106.6 萬 | 0.4% | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 12,500 | $89.8 萬 | 0.4% | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM | 476,948 | $65.3 萬 | 0.3% | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 20,000 | $49.1 萬 | 0.2% | 歷史 |